Add Company
Join Now

ProKidney Corp. Revenue and Competitors

License our Company Data API

Winston-Salem, NC USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ProKidney Corp.'s estimated annual revenue is currently $18.9M per year.(i)
  • ProKidney Corp.'s estimated revenue per employee is $155,000

Employee Data

  • ProKidney Corp. has 122 Employees.(i)
  • ProKidney Corp. grew their employee count by 54% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is ProKidney Corp.?

ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function. Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022. For more information, visit www.prokidney.com.

keywords:N/A

N/A

Total Funding

122

Number of Employees

$18.9M

Revenue (est)

54%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.3M122-1%N/A
#2
$30.5M1248%N/A
#3
N/A124N/AN/A
#4
$21.8M136-34%N/A
#5
$37M13712%N/A